In partnership with International Society of Nephrology (ISN)
With support from AstraZeneca, Boehringer Ingelheim & Lilly, and Novartis

Advancing kidney care for all:
Expanding access to
lifesaving therapies

Wednesday, May 29, 2024 | 9 a.m. CET


About the Event


Kidney disease has often been described as the most neglected chronic disease. Every year at least 5 million people could die from kidney disease, many from lack of access to critical treatments. And by 2040 chronic kidney disease, or CKD, is projected to become the fifth leading cause of years of life lost worldwide.

CKD spans communicable and noncommunicable disease, maternal and child health, and is impacted by and impacts climate change. Kidney disease is exacerbated by poverty and vulnerability, and is associated with mental health disorders, poor oral health, and is an important contributor to death from cardiovascular diseases, diabetes and cancer.

The impact of CKD is especially devastating for patients in low- and middle-income countries (LMICs) where it’s often not detected and treated early, meaning that important opportunities are lost to prevent and treat CKD. Many patients present very late in the course of disease and must face catastrophic health expenditure trying to access costly treatments such as dialysis and kidney transplants, or die.

This event, hosted by Devex in partnership with the International Society of Nephrology on the occasion of the 77th session of the World Health Assembly in Geneva, will explore what’s needed to guarantee kidney health for all, including the need to improve CKD awareness, diagnosis and access to quality care, and capacity building of the health care workforce. The event will bring together a diverse group of experts to discuss what’s needed to implement multisectoral, holistic approaches to CKD, and will also count on patient voices to help shed light on existing gaps in access to treatment and care.

Watch

Schedule


​​8:00 a.m. CET

Networking breakfast and registration

​​9:00 a.m. CET

Opening remarks

• Richard Jones, Editorial Director, Devex

​​9:03 a.m. CET

Fireside chat: Ensuring access to lifesaving treatment for CKD

• Dr. Valerie Luyckx, chair of advocacy working group, International Society of Nephrology
• Daniel Gallego, President of the European Kidney Patients’ Federation

Interviewed by: Alli Blount, Director of Partnerships, Devex

​​9:18 a.m. CET

Panel conversation: Implementing holistic approaches to kidney health in low-income settings

• Dr. Bianca Hemmingsen, Medical officer working on diabetes, World Health Organization
• Alison Cox, Policy & Advocacy Director, NCD Alliance
• Dr. Anna Stavdal, Immediate Past President and WHO Liaison, World Organization of Family Doctors (WONCA)

Interviewed by: Jenny Lei Ravelo, Senior Reporter, Devex

​​9:48 a.m. CET

Audience Q&A

• Dr. Cordón Cruz, Minister of Public Health and Social Assistance, Guatemala

Interviewed by: Jenny Lei Ravelo, Senior Reporter, Devex

​​9:58 a.m. CET

Closing remarks

• Richard Jones, Editorial Director, Devex


Speakers:

Alison Cox

Alison Cox

Policy & Advocacy Director, NCD Alliance

Dr. Anna Stavdal

Dr. Anna Stavdal

Immediate Past President and WHO Liaison, World Organization of Family Doctors (WONCA)

Dr. Valerie Luyckx

Dr. Valerie Luyckx

Chair of advocacy working group, International Society of Nephrology

Dr. Bianca Hemmingsen

Dr. Bianca Hemmingsen

Medical officer working on diabetes, World Health Organization

Daniel Gallego

Daniel Gallego

President of the European Kidney Patients’ Federation

Dr. Cordón Cruz

Dr. Cordón Cruz

Minister of public health and social assistance, Guatemala

Hosted by:

Devex

in partnership with:

ISN

With support from:

AstraZeneca Boehringer Ingelheim & Lilly Novartis